razoxane has been researched along with Abnormalities, Autosome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Anteet, AA; Al-Harbi, MM; Al-Rasheed, NM; Alhaider, AA; Attia, SM | 1 |
| Eastmond, DA; Roy, SK | 1 |
| Eastmond, DA; Hasegawa, LS; Vuong, MC | 1 |
| Li, XF; Tu, ZH; Ye, H | 1 |
| Chen, SQ; Ma, GJ; Wu, JZ; Xue, KX | 1 |
| Franchitto, A; Mosesso, P; Palitti, F; Pichierri, P | 1 |
| Albanese, R; Watkins, PA | 1 |
7 other study(ies) available for razoxane and Abnormalities, Autosome
| Article | Year |
|---|---|
Protection of mouse bone marrow from etoposide-induced genomic damage by dexrazoxane.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Chromosome Aberrations; Etoposide; Glutathione; Lipid Peroxidation; Male; Mice; Micronucleus Tests; Oxidative Stress; Razoxane | 2009 |
Bimolane induces multiple types of chromosomal aberrations in human lymphocytes in vitro.
Topics: Antineoplastic Agents; Cells, Cultured; Chromosome Aberrations; Humans; In Situ Hybridization, Fluorescence; Leukemia; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Mutagens; Neoplasms, Second Primary; Nondisjunction, Genetic; Polyploidy; Razoxane | 2011 |
A comparative study of the cytotoxic and genotoxic effects of ICRF-154 and bimolane, two catalytic inhibitors of topoisomerase II.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Chromosome Aberrations; Cytokinesis; Humans; Lymphocytes; Micronucleus Tests; Mutagenicity Tests; Mutagens; Razoxane; Topoisomerase II Inhibitors | 2013 |
[Leukemia associated with bimkolane].
Topics: Adolescent; Adult; Aged; Animals; Chromosome Aberrations; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mice; Micronucleus Tests; Middle Aged; Psoriasis; Razoxane; Retrospective Studies | 1994 |
[Mutagenic effects of bimolane].
Topics: Animals; Antineoplastic Agents; Chromosome Aberrations; Mice; Mutagenicity Tests; Mutagens; Razoxane | 1995 |
Catalytic inhibition of topoisomerase II in Werner's syndrome cell lines enhances chromosomal damage induced by X-rays in the G2 phase of the cell cycle.
Topics: Catalysis; Cell Line; Chromosome Aberrations; DNA Damage; G2 Phase; Humans; Razoxane; Topoisomerase II Inhibitors; Werner Syndrome; X-Rays | 2000 |
The mutagenic activity of razoxane (ICRF 159): an anticancer agent.
Topics: Animals; Bone Marrow; Chromosome Aberrations; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Erythrocytes; Metaphase; Mice; Mice, Inbred Strains; Microsomes; Mutagenicity Tests; Mutagens; Piperazines; Razoxane; Salmonella typhimurium | 1985 |